Personal
- Accounts & Deposits
  - Accounts
  - Al Hayrat Account
  - Current Account
  - Fixed Deposits Account
  - Money Maker Account
  - Salary Transfer Account
  - Starmaker Account
  - Super Saver Account
  - Al Wajaha
  - Overview
  - BBK Lite
  - Overview
  - NRI
  - NRI Services
  - Debit Cards
  - Classic
  - Gold
  - Signature
  - Infinite
  - Self-service Banking
  - ATM
  - Deposit Machines
  - Interactive Teller Machines
  - Bank Certificates Issuance Machines
  - Debit Card Issuance Machines
  - Foreign Exchange
  - Remittance
  - American Express
- Credit Cards & Financing
  - Credit Cards
  - Platinum
  - Signature
  - Infinite
  - Financing
  - Car Finance
  - Personal Finance
  - Mazaya Mortgage Financing Scheme
  - Mortgage Finance
  - Finance for Women
  - Finance for Doctors
  - Finance for Retirees
- Insurance & Investments
  - Insurance
  - Home Secura
  - Motor Secura
  - Travel Secura
  - Investment
  - Bonds
  - IPO
  - Mutual Funds
  - Real Estate Investment
- Ways to Bank
  - Branches and Self-Service
  - Branches
  - ATM
  - Deposit Machines
  - Debit Card Issuance Machines
  - Corporate Deposit Machines
  - Interactive Teller Machines
  - Bank Certificates Issuance Machines
  - Contactless Payments
  - Apple Pay
  - Samsung Wallet
  - Google Pay
  - Garmin Pay
  - Fitbit Pay
  - More Ways to Bank
  - Mobile app & Online Banking
  - eStatements
  - BBK BanKey
  - Corporate Deposit Card
  - Debit Card
  - Telebanking
  - Open Banking
  - AFAQ Payment System
  - Remittance
  - Visa Click to Pay
  - Sign Language
  - Sign Language Directory
- Help
  - Help & Support
  - Customer Care
  - Complaints and feedback
  - Download Center
  - Updating Customers' Information
  - Sign Language Directory
  - Fraud and security
  - How BBK Protects You
  - How To Protect Yourself
  - Personal Data Privacy
  - Report An Incident
  - Types of Fraud
  - FAQs
  - ePIN Online Generation
  - IBAN Generator
Business
- Cash Management
  - Accounts
  - Business Current Account
  - Business Fixed Deposit Account
  - Cash Management
  - Bankey eBanking
  - Payroll Services
  - Deposit Machines
  - POS Credimax
  - Remittance
- Lending
  - Working Capital Finance
  - Overdraft
  - Cheque discounting
  - Short Term Loans
  - Long Term Finance
  - Project Finance
  - Assets Finance
  - Real estate Finance
- Trade Finance
  - Trade Finance
  - Letters of Credit: Import/Export
  - Letters of Gaurantee
  - Documentary Collection
- Treasury and Investment
  - Treasury
  - Foreign Exchange
  - Hedging Solutions
  - Liquidity Investment Solutions
- Banking & Institutions
  - Corporate Banking
  - Government Affairs
  - Real Estate, Services and Trading
  - Contracting, Building Material, and Manufacturing
  - International Banking
  - Overview
  - Services
  - NRI
  - Offshore Branches
  - Representative offices
  - Enterprise Banking
  - Overview
- Help
  - Help & Support
  - Customer Care
  - Complaints and feedback
  - Download Center
  - Updating Customers' Information
  - Fraud and security
  - How BBK Protects You
  - How To Protect Yourself
  - Personal Data Privacy
  - Report An Incident
  - Types of Fraud
  - FAQs
  - ePIN Online Generation
  - IBAN Generator
PREMIUM
Investor Relations
Who We Are
Media Center

Hikma pharm acquires US Boehringer unit for USD2.65b

29 Jul 2015

(MENAFN) Jordan’s Hikma Pharmaceuticals said it is buying US generic drugs business of Boehringer Ingelheim for USD2.65 billion in a cash-and-stock deal, Arab News reported.

Hikma Pharmaceuticals, which produces and markets branded and non-branded generic and injectable drugs, said the Boehringer purchase would make it the sixth biggest provider of generic drugs in the US.

The move comes as the Jordanian firm is looking to expand in the US. It strengthened its injectable drugs business there when it bought manufacturing assets from Germany’s Boehringer last year.

“We won’t be the size of Teva and other big companies, but we will be bigger than many other companies that were ahead of us over the last five years,” Hikma CEO Said in a statement.

More News

This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more